ClinicalTrials.gg
Sign In

Reperfusion Injury clinical trials

The registry lists 260 studies for Reperfusion Injury across more than 10 countries. 43 are recruiting or about to start. 143 of them are mainly about Reperfusion Injury (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 3 narrower conditions too, such as Myocardial Reperfusion Injury: 360 studies, 63 open.

Get an email when these change. Save the Reperfusion Injury studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
145
Status unknown
50
Recruiting
28
Not yet recruiting
15
Terminated
10
Withdrawn
8

Phase

Phase 2
53
Phase 4
28
Phase 1
24
Phase 3
23
Early Phase 1
2

Where

United States
44
China
33
Netherlands
23
United Kingdom
11
Italy
11
Canada
11

Who runs them

Radboud University Medical Center (17) · Chinese PLA General Hospital (6) · Medical University of Vienna (5) · Hospices Civils de Lyon (3) · Dompé Farmaceutici S.p.A (3) · University of Zurich (3) · Mansoura University (3) · University of Sao Paulo General Hospital (2)

What is being tested here

Drugs under test in Reperfusion Injury studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Morphine202
Treprostinil113
Oxygen112
Ursodeoxycholic Acid102
Empagliflozin102
Pegcetacoplan101
Vitamin B 6101
Pyridoxine101
Furosemide101
Mannitol101

Drug classes tested here SGLT2 inhibitors 1 open · Inhaled anesthetics 6 · Statins 5 · Calcineurin inhibitors 3 · GLP-1 receptor agonists 3

Coming up

2phase 3 studies under way
12studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 28 Reperfusion Injury studies recruiting now, 16 (57%) set no upper age limit and 7 (25%) stop at 75 or younger. 1 (4%) take children under 18. 1 (4%) are for women only and 0 (0%) for men only; 1 (4%) take healthy volunteers.

Recruiting studies that take each age, of 28
AgeWomenMen
101 (4%)1 (4%)
1826 (93%)25 (89%)
3027 (96%)26 (93%)
4028 (100%)27 (96%)
5028 (100%)27 (96%)
6528 (100%)27 (96%)
7524 (86%)24 (86%)
8519 (68%)19 (68%)

Across all 260 studies, recruiting or not: 40% stop at 75 or younger and 22% at 65; 7% take children; 3% are for women only and 6% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Reperfusion Injury studies take

Of 18 phase 2 interventional studies under Reperfusion Injury, half reached primary completion within 26 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 226 mo16–45 · 18 studies——
Interventional, no phase26 mo15–46 · 50 studies—26 mo15–49 · 46 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 260. Browse all 260 → or search them.